As of 3:55pm ET
| +0.05 / +0.30%|
The 8 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 23.00, with a high estimate of 51.00 and a low estimate of 18.00. The median estimate represents a +38.97% increase from the last price of 16.55.
The current consensus among 9 polled investment analysts is to Hold stock in Acorda Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.